Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Zyprexa IM Manufacturing Issues To Be Discussed By FDA, Lilly March 15

Mar 12 2001

• By The Pink Sheet

Related Content

Schering-Plough Clarinex NDA Approval Awaits Resolution Of GMP Problems

Feb 19 2001

Rx Import Bill Undercuts FDA Approach To Quality Control, Lilly Exec Testifies

Oct 09 2000

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window